Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Dicerna To Be Acquired by Novo Nordisk

Skadden is advising Dicerna Pharmaceuticals, Inc. on its $3.3 billion acquisition by Novo Nordisk.
BACK TO TOP